Valuation AstraZeneca PLC Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 2026-06-25			5-day change	1st Jan Change
71,500.00 ^ARS	+0.85%		+8.01%	+1.35%

01:52am	ASTRAZENECA : Gets a Buy rating from Jefferies	ZD
06-25	Major deals involving US drugmakers and biotechs over the past decade	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	288,219	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	0.14%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	307,464	300,224	292,220
Change	-	12.57%	-0.25%	-1.74%	36.64%	-1.2%	-2.35%	-2.67%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	23.3x	20.3x	17.5x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.42x	4.67x	3.81x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.4x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.55x	4.29x	4.03x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.86x	4.47x	4.08x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	13.8x	12.3x	10.9x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	14.5x	12.7x	11.3x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	29.5x	21.9x	19.2x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.39%	4.58%	5.21%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.337	3.524	3.659
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.8%	1.9%	1.97%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.979	9.145	10.61
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.8%	38.5%	34.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,321	67,157	71,556
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,337	24,470	26,751
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,241	23,587	25,911
Net income ¹	112	3,288	5,961	7,035	10,225	12,488	14,137	16,137
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,245	12,005	4,001
Reference price ²	117.51	135.16	135.02	131.05	185.60	185.83	185.83	185.83
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,550,996	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.86x	12x	24.39x	0.61%	1,006B
JOHNSON & JOHNSON	26.17x	6.03x	16.39x	2.18%	589B
ABBVIE INC.	30.87x	7.21x	14.74x	2.85%	430B
ROCHE HOLDING AG	17.87x	4.45x	10.93x	2.99%	331B
NOVARTIS AG	21.56x	5.56x	13.49x	2.84%	285B
NOVO NORDISK A/S	13.98x	5.17x	10.65x	3.6%	213B
AMGEN INC.	22.94x	6.13x	10.71x	2.86%	190B
GILEAD SCIENCES, INC.	-44.37x	5.36x	29.56x	2.62%	154B
PFIZER INC.	11.07x	2.97x	7.23x	7.4%	135B
Average	14.77x	6.10x	15.34x	3.1%	370.27B
Weighted average by Cap.	22.75x	7.58x	17.35x	2.29%